13F-HR filed by Kynam Capital Management, LP
Kynam Capital Management, LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 31 holding rows worth $651,905,794.
- Accession
- 0001085146-23-001182
- Filer
- CIK 1907884
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 31 entries on the cover page, a total value of $651,905,794 stated on the cover page (in dollars after the unit check, H1), rows summing to $651,905,794 with VALUE read as dollars as filed, 13F file number 028-21939. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,100,000 | $125,180,000 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,603,207 | $104,570,825 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,605,390 | $71,552,232 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,561,187 | $65,182,209 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 703,441 | $33,729,996 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,034,697 | $30,223,499 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 100,000 | $27,809,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,409,098 | $27,266,046 | dollars as filed | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 4,420,349 | $25,814,838 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 501,643 | $17,627,735 | dollars as filed | |
| BURNING ROCK BIOTECH LTD | 12233L107 | SPONSORED ADS | 7,391,581 | $16,631,057 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 300,000 | $15,513,000 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 9,642,240 | $11,667,110 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,752,841 | $11,165,597 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 794,049 | $9,179,206 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 418,099 | $8,792,622 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,238,182 | $8,667,274 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 191,158 | $8,661,369 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 520,922 | $5,683,259 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,025,234 | $4,961,823 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 776,662 | $4,349,307 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,771,545 | $3,844,253 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 404,544 | $3,268,716 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 396,378 | $2,493,218 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 561,609 | $2,375,606 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 733,926 | $2,275,171 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 165,486 | $1,530,746 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 28,887 | $1,139,014 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 739,649 | $641,867 | dollars as filed | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 120,764 | $61,469 | dollars as filed | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 90,484 | $47,730 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-23-001182 | this filing | 2023-02-14 | acceptance time not in the bulk data set |